Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2007 1
2008 2
2009 2
2010 1
2012 1
2013 3
2014 1
2015 1
2016 3
2017 6
2018 3
2019 2
2020 15
2021 13
2022 10
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation and management of pulmonary arterial hypertension.
Beshay S, Sahay S, Humbert M. Beshay S, et al. Among authors: sahay s. Respir Med. 2020 Sep;171:106099. doi: 10.1016/j.rmed.2020.106099. Epub 2020 Aug 19. Respir Med. 2020. PMID: 32829182 Free article. Review.
Rebuttal From Dr Sahay.
Sahay S. Sahay S. Chest. 2024 Mar;165(3):498-499. doi: 10.1016/j.chest.2023.07.4230. Chest. 2024. PMID: 38461014 No abstract available.
Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes.
Nathan SD, Deng C, King CS, DuBrock HM, Elwing J, Rajagopal S, Rischard F, Sahay S, Broderick M, Shen E, Smith P, Tapson VF, Waxman AB. Nathan SD, et al. Among authors: sahay s. Chest. 2023 Feb;163(2):398-406. doi: 10.1016/j.chest.2022.09.007. Epub 2022 Sep 15. Chest. 2023. PMID: 36115497 Free PMC article. Clinical Trial.
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study.
Rahaghi FF, Kolaitis NA, Adegunsoye A, de Andrade JA, Flaherty KR, Lancaster LH, Lee JS, Levine DJ, Preston IR, Safdar Z, Saggar R, Sahay S, Scholand MB, Shlobin OA, Zisman DA, Nathan SD. Rahaghi FF, et al. Among authors: sahay s. Chest. 2022 Jul;162(1):145-155. doi: 10.1016/j.chest.2022.02.012. Epub 2022 Feb 15. Chest. 2022. PMID: 35176276 Free PMC article.
Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study.
Nathan SD, Waxman A, Rajagopal S, Case A, Johri S, DuBrock H, De La Zerda DJ, Sahay S, King C, Melendres-Groves L, Smith P, Shen E, Edwards LD, Nelsen A, Tapson VF. Nathan SD, et al. Among authors: sahay s. Lancet Respir Med. 2021 Nov;9(11):1266-1274. doi: 10.1016/S2213-2600(21)00165-X. Epub 2021 Jun 29. Lancet Respir Med. 2021. PMID: 34214475 Clinical Trial.
BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension.
Spikes LA, Bajwa AA, Burger CD, Desai SV, Eggert MS, El-Kersh KA, Fisher MR, Johri S, Joly JM, Mehta J, Palevsky HI, Ramani GV, Restrepo-Jaramillo R, Sahay S, Shah TG, Deng C, Miceli M, Smith P, Shapiro SM. Spikes LA, et al. Among authors: sahay s. Pulm Circ. 2022 Apr 7;12(2):e12063. doi: 10.1002/pul2.12063. eCollection 2022 Apr. Pulm Circ. 2022. PMID: 35514770 Free PMC article.
Evaluation, Diagnosis, and Classification of Pulmonary Hypertension.
Sarah B, Ashrith G, Sandeep S. Sarah B, et al. Among authors: sandeep s. Methodist Debakey Cardiovasc J. 2021 Jul 1;17(2):86-91. doi: 10.14797/OCDF4453. eCollection 2021. Methodist Debakey Cardiovasc J. 2021. PMID: 34326927 Free PMC article. Review.
Portopulmonary Hypertension: From Bench to Bedside.
Thomas C, Glinskii V, de Jesus Perez V, Sahay S. Thomas C, et al. Among authors: sahay s. Front Med (Lausanne). 2020 Nov 3;7:569413. doi: 10.3389/fmed.2020.569413. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33224960 Free PMC article. Review.
78 results